Navigation Links
High-Resolution Breast PET Improves Breast Cancer Detection
Date:10/29/2009

SAN DIEGO, Oct. 29 /PRNewswire/ --

AT A GLANCE

  • Positron emission mammography (PEM) improves breast cancer detection.
  • PEM significantly improves ability to differentiate between benign and cancerous lesions.
  • Combination of PEM and breast MRI dramatically increased number of suspicious lesions found.

An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions. The prospective study also found that the combination of PEM and breast MRI dramatically increases a physician's ability to detect potentially cancerous lesions over MRI alone, presenting a powerful combination for improving care. The findings released today mean that women and their physicians now have a better tool to help cure cancer.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091029/LA01618)

PEM scanners are high-resolution breast PET systems that can show the location as well as the metabolic phase of a lesion. This information is critical in determining whether a lesion is malignant and influences the course of treatment. Other imaging systems, such as mammography and ultrasound, only show the location, not the metabolic phase. PEM scanners, which are about the size of an ultrasound system, are made in San Diego by Naviscan, Inc. and have been commercially available since 2007.

The NIH study examined 388 women with newly-diagnosed breast cancers, and unlike previous studies on primary lesions, focused on additional or secondary tumors. Understanding the presence of additional tumors is critical to understanding if a lumpectomy or mastectomy is the right surgery. Researchers found that P
'/>"/>

SOURCE Naviscan, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. New Virtual Microscope System from Hamamatsu Offers Faster Acquisition of High-Resolution Slide Scans
2. Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women
3. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
4. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
5. Do Women Have a Right to a Breastpump That Works? Asks Hygeia
6. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
7. Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
8. Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer
9. Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says
10. New stem cell identification technology could cure breast cancer
11. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
(Date:5/23/2013)... California (PRWEB) May 23, 2013 According ... titled “SBU-Led Study Reveals Nanoparticles Found in Everyday Items ... found in everyday items such as cosmetics and other ... human body. As a result, men and women who ... means that they develop wrinkles earlier than ...
(Date:5/23/2013)... Wei Angela Liu, MD, of Mamaroneck, NY, ... as Medical Director of Physical Medicine and ... rehabilitation care to patients of all ages and stages ... in biochemistry at Columbia College, honored as a Fu ... medical degree at New York University School of Medicine ...
(Date:5/23/2013)... Diversity Focus announced today that in 2013 ... of diversity. The results come from the 2013 Creative ... of this year. 1198 qualified residents took part. The ... its benchmark survey in 2008. , In both 2008 ... of diversity were race and ethnicity. But the numbers ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Mild to moderate ... impact on children,s brain development, British researchers report. ... expectant mother,s diet appear to put her child at ... preteen years, the study authors found. Pregnant women can ... and seafood, the researchers suggested. The finding, published ...
(Date:5/23/2013)... By Steven Reinberg HealthDay Reporter , , THURSDAY, ... frequent heartburn may be at increased risk for cancers ... don,t smoke or drink alcohol, a new study says. ... these cancers while prescription medications such as Prilosec, Nexium ... been a controversy about whether heartburn contributes to cancers ...
Breaking Medicine News(10 mins):Health News:Aging and Wrinkles – Gold Found in Everyday Products Can Accelerate the Visual Signs of Aging 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Diversity Focus Announces Results from the 2013 Creative Corridor Community Survey 2Health News:Low Prenatal Iodine May Affect Child's Brain Development 2Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2
... U.S.,Presidential candidate Hillary Clinton today pledged to expand the ... if elected, setting,the goal of ending malaria-related deaths in ... said this funding would be in addition to U.S.,government ... the Global,Fund to Fight AIDS, Tuberculosis, and Malaria, which ...
... Sumitomo Corporation of America,(SCOA) announced the appointment of ... animal healthcare company, Summit VetPharm, LLC. Mr.,Isohata joins ... 15,years as head of Sumitomo,s Household Insecticides and ... for the Petcare business,in the Life Science Division, ...
... their odds for cardiovascular disease , THURSDAY, Nov. ... cholesterol boosts their heart risks helps them stick ... at McGill University in Montreal enrolled more than ... problems who were instructed to change their lifestyle ...
... 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, ... called apoptosis plays a key role in development, and ... their work. As apoptotic cells degrade, they display standard ... fragmentation. , Now, Harvard Medical School researchers have uncovered ...
... million men and women in the United States live ... that permeates muscles in the neck, back and shoulders. ... understood, but research studies indicate that a new imaging ... definitive diagnosis and, perhaps eventually, new treatments for people ...
... adrenal masses are found incidentally during a CT scan, ... additional imaging follow-up, according to a recent study conducted ... , With increased utilization of CT, we are ... the patients were scanned, the so called incidentalomas, of ...
Cached Medicine News:Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 2Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 2Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 3Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 4Health News:Sumitomo Corporation Appoints New Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC 5Health News:Knowing Heart Risk Keeps Patients on Cholesterol Drugs 2Health News:Homeless cells find temporary lodging -- and their demise 2Health News:Homeless cells find temporary lodging -- and their demise 3Health News:MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows 2
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: